Remicade [infliximab] Therapy in Ankylosing Spondylitis: Investigation of Real Life Regimen in Austria Over 9 Consecutive Infusions.
Phase of Trial: Phase IV
Latest Information Update: 05 Nov 2013
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Sponsors Organon; Schering-Plough
- 08 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Oct 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 26 Aug 2008 New trial record.